Erika Abelleira

Author PubWeight™ 4.00^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Biochemical persistence in thyroid cancer: is there anything to worry about?	Endocrine	2013	1.50
2	Outcomes of patients with differentiated thyroid cancer risk-stratified according to the American thyroid association and Latin American thyroid society risk of recurrence classification systems.	Thyroid	2013	1.11
3	Radioiodine thyroid remnant ablation after recombinant human thyrotropin or thyroid hormone withdrawal in patients with high-risk differentiated thyroid cancer.	J Thyroid Res	2012	0.77
4	Undetectable pre-ablation thyroglobulin levels in patients with differentiated thyroid cancer: it is not always what it seems.	Arq Bras Endocrinol Metabol	2013	0.76
5	Patients with familial non-medullary thyroid cancer have an outcome similar to that of patients with sporadic papillary thyroid tumors.	Arq Bras Endocrinol Metabol	2011	0.75
6	Insulin resistance is another factor that increases the risk of recurrence in patients with thyroid cancer.	Endocrine	2014	0.75
7	Lack of increase in the serum thyroid-stimulating hormone level after intramuscular administration of recombinant human thyroid-stimulating hormone doses in a morbidly obese patient.	Endocr Pract	2011	0.75